Teleflex Incorporated 

$117.73
70
-$0.69-0.58% Today

Statistics

Day High
119.1
Day Low
115.19
52W High
141.64
52W Low
100.18
Volume
136,417
Avg. Volume
986,442
Mkt Cap
5.2B
P/E Ratio
29.01
Dividend Yield
1.15%
Dividend
1.35

Upcoming

Dividends

1.15%Dividend Yield
Mar 26
$0.34
Dec 25
$0.34
Sep 25
$0.34
Jun 25
$0.34
Mar 25
$0.34
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
1.21
2.1
3
3.89
Expected EPS
1.20547
Actual EPS
N/A

Financials

-45.45%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.99BRevenue
-1.81BNet Income

Analyst Ratings

$131.20Average Price Target
The highest estimate is 138.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
40%
Hold
60%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TFX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc is a major competitor in the medical devices sector, offering a wide range of products that compete directly with Teleflex's offerings in areas such as surgical instruments and patient monitoring systems.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation competes in the medical devices market, particularly in areas like interventional medicine, where it offers products that overlap with Teleflex's portfolio.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a broad array of medical devices and services that compete with Teleflex, especially in the critical care and surgical products segments.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices division, competes across several areas with Teleflex, including surgical and interventional solutions.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a wide range of medical devices in areas such as vascular therapy and diagnostics, competing with Teleflex in multiple segments.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew plc competes with Teleflex in the surgical devices market, particularly in advanced wound management and orthopedics.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a competitor in the medical technology field, offering products that compete with Teleflex in surgical, orthopedic, and neurotechnology segments.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes with Teleflex in the musculoskeletal healthcare sector, particularly in areas related to surgical solutions.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation is a competitor in the field of patient monitoring and cardiovascular health, offering products that directly compete with Teleflex's offerings.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. competes with Teleflex in the diagnostics and medical imaging sector, particularly in women's health, where both companies offer overlapping products.

About

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Show more...
CEO
Mr. Liam J. Kelly
Employees
14100
Country
US
ISIN
US8793691069

Listings

0 Comments

Share your thoughts

FAQ

What is Teleflex Incorporated stock price today?
The current price of TFX is $117.73 USD — it has decreased by -0.58% in the past 24 hours. Watch Teleflex Incorporated stock price performance more closely on the chart.
What is Teleflex Incorporated stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Teleflex Incorporated stocks are traded under the ticker TFX.
Is Teleflex Incorporated stock price growing?
TFX stock has risen by +6.66% compared to the previous week, the month change is a -4.13% fall, over the last year Teleflex Incorporated has showed a -16.64% decrease.
What is Teleflex Incorporated market cap?
Today Teleflex Incorporated has the market capitalization of 5.2B
When is the next Teleflex Incorporated earnings date?
Teleflex Incorporated is going to release the next earnings report on April 30, 2026.
What were Teleflex Incorporated earnings last quarter?
TFX earnings for the last quarter are 1.93 USD per share, whereas the estimation was 3.76 USD resulting in a -48.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Teleflex Incorporated revenue for the last year?
Teleflex Incorporated revenue for the last year amounts to 3.99B USD.
What is Teleflex Incorporated net income for the last year?
TFX net income for the last year is -1.81B USD.
Does Teleflex Incorporated pay dividends?
Yes, TFX dividends are paid quarterly. The last dividend per share was 0.34 USD. As of today, Dividend Yield (FWD)% is 1.15%.
How many employees does Teleflex Incorporated have?
As of April 02, 2026, the company has 14,100 employees.
In which sector is Teleflex Incorporated located?
Teleflex Incorporated operates in the Health Care sector.
When did Teleflex Incorporated complete a stock split?
Teleflex Incorporated has not had any recent stock splits.
Where is Teleflex Incorporated headquartered?
Teleflex Incorporated is headquartered in Wayne, US.